Related Experiment Videos
Lung cancer profiling: Genetic and molecular predictors of MEK-dependence
Aphrothiti J Hanrahan1, David B Solit
1Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Cancer Biology & Therapy
|October 27, 2009
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Comprehensive clinical and genomic analysis of early onset cancer of the bladder and upper urinary tract.
Journal of the National Cancer Institute·2026
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary Cancers.
medRxiv : the preprint server for health sciences·2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
The molecular mechanisms of platelets in tumor invasion and metastasis: a controversial role.
Cancer biology & therapy·2026
Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics.
Cancer biology & therapy·2026
DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapy.
Cancer biology & therapy·2026
Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.
Drug design, development and therapy·2026
PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.
Molecular therapy. Nucleic acids·2026
miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.
Molecular therapy. Nucleic acids·2026